from Oppenheimer issued a price target of $115.00 for GHM on 2026-10-08 11:44:40.The adjusted price target was set to $115.00.At the time of the announcement, GHM was trading at $84.34.The overall price target consensus is at $132.50 with high price of $135.00, low price of $130.00, and median price is at $132.50.GHM currently trades -32.97%...
AngioDynamics, Inc. (ANGO) confirmed earnings release on October 08, 2026, Before the market for the quarter...
Comtech Telecommunications Corp. (CMTL) confirmed earnings release on October 08, 2026, Before the market for the...
Toro Corp. (TORO) confirmed earnings release on October 08, 2026, Before the market for the quarter...
Bank of South Carolina Corporation (BKSC) confirmed earnings release on October 08, 2026, for the quarter...
from Oppenheimer issued a price target of $115.00 for GHM on 2026-10-08 11:44:40.The adjusted price target was set to $115.00.At the time of the announcement, GHM was trading at $84.34.The...
Kambiz Yazdi from Jefferies issued a price target of $39.00 for ARQT on 2026-10-08 08:23:00.The adjusted price target was set to $39.00.At the time of the announcement, ARQT was trading...
Adam Kroll from Piper Sandler issued a price target of $20.00 for LCNB on 2026-10-08 07:52:00.The adjusted price target was set to $20.00.At the time of the announcement, LCNB was...
Brad Zelnick from Deutsche Bank issued a price target of $35.00 for VIA on 2026-10-07 13:02:40.The adjusted price target was set to $35.00.At the time of the announcement, VIA was...
from Lake Street issued a price target of $10.00 for FOSL on 2026-10-07 11:34:24.The adjusted price target was set to $10.00.At the time of the announcement, FOSL was trading at...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
